Cited by 41Hemoglobinopathies and Related DisordersPulmonary Hypertension Research and TreatmentsCongenital Heart Disease Studies

Estimated pulmonary artery systolic pressure and sickle cell disease: a meta‐analysis and systematic review

Open access
Caughey, Melissa C., Poole, Charles, Ataga, Kenneth I., Hinderliter, Alan L.·2015·British Journal of Haematology

Abstract

Summary: Many studies report estimated pulmonary artery systolic pressure (ePASP) in patients with sickle cell disease (SCD) screened by echocardiography. To better understand the prevalence and outcomes of elevated ePASP in clinically stable SCD patients, we conducted a random‐effects meta‐analysis. A total of 45 studies, representing 15 countries and including 6109 individuals, met our inclusion criteria. In most (70%) studies, elevated ePASP was defined by a tricuspid regurgitant velocity of 2·5 m/s. The prevalence of elevated ePASP was 21% (17–26%) in children and 30% (26–35%) in adults. After adjustment for sex, SCD genotype, haemoglobin, hydroxycarbamide (hydroxyurea) treatment, country and publication year, age remained associated with elevated ePASP, yielding a 12% (0·4–23%) higher adjusted prevalence in adults. Few studies reported 6‐min walk tests or mortality outcomes, and estimates were highly heterogeneous. In random effects meta‐analyses, patients with elevated ePASP walked an estimated 30·4 (6·9–53·9) metres less than those without elevated ePASP and had an associated mortality hazard ratio of 4·9 (2·4–9·7).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjh.13447

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A meta-analysis of 45 screening studies from 15 countries of more than 6,000 patients indicates that the prevalence of elevated tricuspid regurgitant jet velocity ≥2.5 m/s is 30% (range 26-35%) in adults.

    “A meta-analysis of 45 screening studies from 15 countries of more than 6,000 patients indicates that the prevalence of elevated tricuspid regurgitant jet velocity ≥2.5 m/s is 30% (range 26–35%) in adults.”

    From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [191]

    The Results report 45 studies from 15 countries involving 6,109 people and an estimated 30% prevalence of elevated estimated pulmonary artery systolic pressure among adults with sickle cell disease. However, the studies used varying definitions of elevation: the reported 30% (26–35%) is not specifically the prevalence of TRV ≥2.5 m/s, although the Results say restricting analyses to that threshold did not substantially change the estimates. The 26–35% figures are a 95% confidence interval, not a range of observed prevalence. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Patients with elevated tricuspid regurgitant jet velocity walked an estimated 30.4 (6.9-53.9) meters less than those without elevated tricuspid regurgitant jet velocity, with an associated hazard ratio for death of 4.9 (2.4-9.7).

    “Patients with elevated tricuspid regurgitant jet velocity walked an estimated 30.4 (6.9–53.9) meters less than those without elevated tricuspid regurgitant jet velocity, with an associated hazard ratio for death of 4.9 (2.4–9.7) (191).”

    From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [191]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [14]14. Cabrita, I.Z., Mohammed, A., Layton, M., Ghorashian, S., Gilmore, A., Cho, G., Howard, J., Anie, K.A., Desforges, L., Bassett, P., Grapsa, J., Howard, L., Mahalingam, G., Dawson, D., Pinto, F.J., Nihoyannopoulos, P., Davies, S.C. & Gibbs, J.S. (2013) The association between tricuspid regurgitation velocity and 5-year sur- vival in a North West London population of patients with sickle cell disease in the United Kingdom. British Journal of Haematology, 162, 400-408.

Cited by

Sorted by citations

Authors
Caughey, M. C., Poole, C., Ataga, K. I., & Hinderliter, A. L.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
Caughey, Melissa C.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2015-04-09
Volume
170
Issue
3
Pages
416-424
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2138288711
Cited by
41
References
61
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 6 · 2016: 8 · 2015: 1
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • British Journal of Haematology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Epidemiology › Congenital Heart Disease Studies
Keywords
sickle cell disease, pulmonary artery systolic pressure, tricuspid regurgitation velocity, echocardiography, prevalence, 6-minute walk test, mortality, hydroxyurea, children and adults
MeSH terms
Adult, Anemia, Sickle Cell, Antisickling Agents, Echocardiography, Female, Humans, Hydroxyurea, Male, Pulmonary Artery, Prevalence, Arterial Pressure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review